Benitec Biopharma annual current ratio
2019
2020
2021
2022
2023
2024
2025
Benitec Biopharma Current Ratio Growth & History (BNTC)
Benitec Biopharma's current ratio was 54.67 for fiscal 2025.
View full Benitec Biopharma company overviewBenitec Biopharma annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | 54.67 | 44.18 | +420.96% |
| 2024 | 2024-06-30 | 10.49 | 9.56 | +1019.51% |
| 2023 | 2023-06-30 | 0.94 | −0.97 | −50.76% |
| 2022 | 2022-06-30 | 1.90 | −13.15 | −87.35% |
| 2021 | 2021-06-30 | 15.05 | 5.54 | +58.21% |
| 2020 | 2020-06-30 | 9.51 | 2.41 | +33.98% |
| 2019 | 2019-06-30 | 7.10 | — | — |
Benitec Biopharma quarterly current ratio
Q4.19
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | 56.82 | 42.01 | +283.80% |
| Q2 2026 | 2025-12-31 | 67.69 | 42.21 | +165.63% |
| Q1 2026 | 2025-09-30 | 46.95 | 31.94 | +212.83% |
| Q4 2025 | 2025-06-30 | 54.67 | 44.18 | +420.96% |
| Q3 2025 | 2025-03-31 | 14.80 | 10.62 | +254.17% |
| Q2 2025 | 2024-12-31 | 25.48 | 21.86 | +604.07% |
| Q1 2025 | 2024-09-30 | 15.01 | 9.18 | +157.65% |
| Q4 2024 | 2024-06-30 | 10.49 | 9.56 | +1019.51% |
| Q3 2024 | 2024-03-31 | 4.18 | 1.83 | +78.21% |
| Q2 2024 | 2023-12-31 | 3.62 | −0.79 | −17.92% |
| Q1 2024 | 2023-09-30 | 5.83 | 0.15 | +2.69% |
| Q4 2023 | 2023-06-30 | 0.94 | −0.97 | −50.76% |
| Q3 2023 | 2023-03-31 | 2.35 | −2.29 | −49.36% |
| Q2 2023 | 2022-12-31 | 4.41 | −0.70 | −13.70% |
| Q1 2023 | 2022-09-30 | 5.67 | −4.55 | −44.53% |
| Q4 2022 | 2022-06-30 | 1.90 | −13.15 | −87.35% |
| Q3 2022 | 2022-03-31 | 4.63 | −0.45 | −8.77% |
| Q2 2022 | 2021-12-31 | 5.11 | −13.35 | −72.33% |
| Q1 2022 | 2021-09-30 | 10.23 | 2.32 | +29.35% |
| Q4 2021 | 2021-06-30 | 15.05 | 5.54 | +58.21% |
| Q3 2021 | 2021-03-31 | 5.08 | — | — |
| Q2 2021 | 2020-12-31 | 18.46 | — | — |
| Q1 2021 | 2020-09-30 | 7.91 | — | — |
| Q4 2020 | 2020-06-30 | 9.51 | 2.41 | +33.98% |
| Q4 2019 | 2019-06-30 | 7.10 | — | — |
Benitec Biopharma current ratio trends
Over the last five fiscal years, Benitec Biopharma's current ratio increased from 9.51 to 54.67, a change of 45.16. The latest reported quarter, Q3 2026, shows 56.82.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Benitec Biopharma source filings ↗